C1q receptors: Regulating specific functions of phagocytic cells

被引:48
作者
Tenner, AJ [1 ]
机构
[1] Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA
关键词
D O I
10.1016/S0171-2985(98)80031-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A C1q receptor that upregulates the phagocytic capacity of professional phagocytes, C1qR(p), has been identified, and its primary structure determined by cDNA cloning and sequencing. Monoclonal antibodies that immunoprecipitate this 126,000 Mr polypeptide inhibit the enhancement of phagocytosis triggered not only by C1q but also by mannose binding lectin (MBL) and pulmonary surfactant protein A (SPA) providing critical evidence that this polypeptide is a functional receptor or component of the receptor that mediates this enhancement of phagocytosis. The amino acid sequence, deduced from the cloned cDNA coding for this receptor, indicates that this surface glycoprotein receptor is a novel type I membrane protein of 631 amino acid containing a region homologous to C-type lectin carbohydrate recognition domains, 5 EGF-like domains, a single transmembrane domain and a 47 amino acid intracellular domain. Expression of this receptor is limited to cells of myeloid origin, platelets and endothelial cells, consistent with a relatively selective function, and making it an attractive candidate for therapeutic modulation of function. A distinct C1q receptor that triggers superoxide in polymorphonuclear leukocytes has been functionally characterized and designated as C1qR(O2-). Thus, the accumulated data that will be summarized here demonstrate that there are at least two C1q receptor/receptor complexes (C1qR(p) and C1qR(O2-)), each triggering distinct cellular responses, that multiple C1q receptors can be expressed on the same, as well as on different, cell types, and that at least one C1q receptor, C1qR(p), is capable of responding to multiple ligands.
引用
收藏
页码:250 / 264
页数:15
相关论文
共 70 条
[1]   PGG-glucan activates NF-kappa B-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line [J].
Adams, DS ;
Pero, SC ;
Petro, JB ;
Nathans, R ;
Mackin, WM ;
Wakshull, E .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (06) :865-873
[2]   ROLE OF COMPLEMENT COMPONENT C1Q IN PHAGOCYTOSIS OF LISTERIA-MONOCYTOGENES BY MURINE MACROPHAGE-LIKE CELL-LINES [J].
ALVAREZDOMINGUEZ, C ;
CARRASCOMARIN, E ;
LEYVACOBIAN, F .
INFECTION AND IMMUNITY, 1993, 61 (09) :3664-3672
[3]  
ANDREWS BS, 1981, J IMMUNOL, V127, P1075
[4]   RANDOMIZED PHASE I/II TRIAL OF A MACROPHAGE-SPECIFIC IMMUNOMODULATOR (PGG-GLUCAN) IN HIGH-RISK SURGICAL PATIENTS [J].
BABINEAU, TJ ;
MARCELLO, P ;
SWAILS, W ;
KENLER, A ;
BISTRIAN, B ;
FORSE, RA .
ANNALS OF SURGERY, 1994, 220 (05) :601-609
[5]   C1Q ACTS SYNERGISTICALLY WITH PHORBOL DIBUTYRATE TO ACTIVATE CR1-MEDIATED PHAGOCYTOSIS BY HUMAN MONONUCLEAR PHAGOCYTES [J].
BOBAK, DA ;
FRANK, MM ;
TENNER, AJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :2001-2007
[6]  
BOBAK DA, 1987, J IMMUNOL, V138, P1150
[7]  
BOBAK DA, 1988, J IMMUNOL, V141, P592
[8]  
BOWNESS P, 1994, Q J MED, V87, P455
[9]   MECHANISM OF INHIBITION OF IMMUNOGLOBULIN G-MEDIATED PHAGOCYTOSIS BY MONOCLONAL-ANTIBODIES THAT RECOGNIZE THE MAC-1 ANTIGEN [J].
BROWN, EJ ;
BOHNSACK, JF ;
GRESHAM, HD .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :365-375
[10]  
Chaka W, 1997, J IMMUNOL, V159, P2979